US Patent 7507809 RNAi modulation of RSV and therapeutic uses thereof
Patent 7507809 was granted and assigned to Alnylam Pharmaceuticals on March, 2009 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7507809 RNAi modulation of RSV and therapeutic uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
